IFP Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $276 | Buy |
377
+153
| +68% | +$112 | ﹤0.01% | 4572 |
|
|
2025
Q1 | $181 | Hold |
224
| – | – | ﹤0.01% | 3693 |
|
|
2024
Q4 | $309 | Buy |
+224
| New | +$309 | ﹤0.01% | 3560 |
|
|
2023
Q1 | – | Sell |
-1,000
| Closed | -$16K | – | 3540 |
|
|
2022
Q4 | $16K | Buy |
+1,000
| New | +$16K | ﹤0.01% | 3057 |
|
|
2022
Q1 | – | Sell |
-53
| Closed | -$1K | – | 4551 |
|
|
2021
Q4 | $1K | Buy |
+53
| New | +$1K | ﹤0.01% | 2910 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3521 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3243 |
|
|
2021
Q1 | – | Sell |
-18
| Closed | – | – | 3163 |
|
|
2020
Q4 | $0 | Sell |
18
-17
| -49% | – | ﹤0.01% | 3083 |
|
|
2020
Q3 | $0 | Buy |
+35
| New | – | ﹤0.01% | 2959 |
|
|
2020
Q2 | – | Sell |
-161
| Closed | -$3K | – | 2843 |
|
|
2020
Q1 | $3K | Buy |
161
+21
| +15% | +$391 | ﹤0.01% | 2197 |
|
|
2019
Q4 | $3K | Hold |
140
| – | – | ﹤0.01% | 2340 |
|
|
2019
Q3 | $3K | Buy |
+140
| New | +$3K | ﹤0.01% | 2508 |
|